C32H29F5N3NaO5
653.6 g/mol
Aktif Farmasötik İngredientTehlike
Elagolix sodium
CAS832720-36-2
Kategori
Aktif Farmasötik İngredient
Bileşik Sınıfı
Diğer
Birincil Kullanım
Farmasötik ham madde
Elagolix sodium is a pharmaceutical raw material used as a gonadotropin-releasing hormone antagonist. It is primarily supplied for the manufacturing of medications indicated for endometriosis-associated pain.
pharmaceutical raw material for gonadotropin-releasing hormone antagonist productsactive pharmaceutical ingredient for research and manufacturing in women's health
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 832720-36-2
İlgili Bileşikler
GüçlüBenzer yapıBenzerlik 0.85
Ethyl 4-(((1R)-2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-3,6-dihydro-1(2H)-pyrimidinyl)-1-phenylethyl)amino)butanoate
CAS832720-84-0
Elagolix intermediate
GüçlüBenzer yapıBenzerlik 0.85
Ethyl (R)-4-((2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl)-1-phenylethyl)amino)butanoate hydrochloride
CAS1150560-46-5
pharmaceutical intermediate
BenzerBenzer yapıBenzerlik 0.73
1,1-Dimethylethyl N-[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6-dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]carbamate
CAS830346-51-5
Pharmaceutical intermediate for elagolix
UygulamaAynı kullanım
Linzagolix
CAS935283-04-8
gonadotropin-releasing hormone antagonist
UygulamaAynı kullanım
Ganirelix
CAS123246-29-7
gonadotropin-releasing hormone antagonist
UygulamaAynı kullanım
Ganirelix
CAS124904-93-4
gonadotropin-releasing hormone antagonist
UygulamaAynı kullanım
Ganirelix acetate
CAS129311-55-3
gonadotropin-releasing hormone antagonist
ReferansAynı kategori
Ofloxacin
CAS83380-47-6
active pharmaceutical ingredient
Güvenlik Referansı
Tehlike
H304May be fatal if swallowed and enters airways
H319Causes serious eye irritation
H360May damage fertility or the unborn child
H361Suspected of damaging fertility or the unborn child
Tanımlayıcılar
IUPAC Adı
sodium 4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2,6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoate
InChIKey
DQYGXRQUFSRDCH-UQIIZPHYSA-M
SMILES
CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)C[C@@H](C3=CC=CC=C3)NCCCC(=O)[O-])C4=C(C(=CC=C4)OC)F.[Na+]
Eş Anlamlılar (18)
- Elagolix sodium (USAN)
- 832720-36-2 (sodium)
- Elagolix sodium
- Elagolix sodium (Standard)
- Elagolix sodium salt
- NBI-56418 NA
- NBI-56418 sodium
- NBI56418; ABT-620
- Orilissa (TN)
- Orlissa